-transparent.png){kind=logo}
New mitomycin C and porfiromycin analogues were prepared by treating mitomycin A and N-methylmitomycin A with a variety of amines, including aziridines, allylamines, propargylamines, chloroalkylamines, hydroxyalkylamines, glycine derivatives, aralkylamines, and heterocyclic amines. All analogues were evaluated against P-388 murine leukemia and selected ones were examined for their leukopenic properties. Certain analogues were found to be superior to mitomycin C in potency, efficacy, and therapeutic ratio in the P-388 assay. The most active substituents at the mitosane 7 position included aziridine, 2-methylaziridine, propargylamine, furfurylamine, methyl glycinate, and 3-aminopyridine. Mitomycin A and the 7-aziridino, 7-(2-methylaziridino), and 3-aminopyridine analogues were less leukopenic than mitomycin C. Certain other analogues, including propargylamino and methyl glycinate, were highly leukopenic. The three compounds tested against B-16 melanoma in mice were significantly more effective than mitomycin C in this assay. Previously established structure--activity relationships were found inadequate to account for all of the new data.
B S Iyengar, and
H J Lin, and
L Cheng, and
W A Remers, and
W T Bradner
January 1983,
Journal of medicinal chemistry,
B S Iyengar, and
H J Lin, and
L Cheng, and
W A Remers, and
W T Bradner
January 1985,
Journal of natural products,
B S Iyengar, and
H J Lin, and
L Cheng, and
W A Remers, and
W T Bradner
September 1964,
Science (New York, N.Y.),
B S Iyengar, and
H J Lin, and
L Cheng, and
W A Remers, and
W T Bradner
December 1993,
Molecular pharmacology,
B S Iyengar, and
H J Lin, and
L Cheng, and
W A Remers, and
W T Bradner
July 1962,
Antibiotics & chemotherapy (Northfield, Ill.),
B S Iyengar, and
H J Lin, and
L Cheng, and
W A Remers, and
W T Bradner
March 1994,
Cell proliferation,
B S Iyengar, and
H J Lin, and
L Cheng, and
W A Remers, and
W T Bradner
June 1993,
Molecular pharmacology,
B S Iyengar, and
H J Lin, and
L Cheng, and
W A Remers, and
W T Bradner
July 1991,
Journal of medicinal chemistry,
B S Iyengar, and
H J Lin, and
L Cheng, and
W A Remers, and
W T Bradner
January 1989,
Anticancer research,
B S Iyengar, and
H J Lin, and
L Cheng, and
W A Remers, and
W T Bradner
July 1989,
Journal of chromatography,
